HCA Holdings Given New $72.00 Price Target at JPMorgan Chase & Co. (HCA)
Analysts at JPMorgan Chase & Co. boosted their price objective on shares of HCA Holdings (NYSE:HCA) from $60.00 to $72.00 in a research report issued to clients and investors on Thursday. JPMorgan Chase & Co.’s target price would suggest a potential upside of 9.94% from the stock’s previous close.
In other HCA Holdings news, SVP David Gwin Anderson sold 22,524 shares of the company’s stock on the open market in a transaction dated Wednesday, July 30th. The stock was sold at an average price of $66.53, for a total value of $1,498,521.72. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Shares of HCA Holdings (NYSE:HCA) traded up 0.28% on Thursday, hitting $65.49. 3,627,152 shares of the company’s stock traded hands. HCA Holdings has a 52 week low of $37.75 and a 52 week high of $66.71. The stock’s 50-day moving average is $58.65 and its 200-day moving average is $52.79. The company has a market cap of $29.668 billion and a P/E ratio of 18.51.
HCA Holdings (NYSE:HCA) last announced its earnings results on Tuesday, July 29th. The company reported $1.07 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.92 by $0.15. The company had revenue of $9.96 billion for the quarter, compared to the consensus estimate of $8.98 billion. During the same quarter last year, the company posted $0.91 earnings per share. HCA Holdings’s revenue was up 5.1% compared to the same quarter last year. On average, analysts predict that HCA Holdings will post $4.17 earnings per share for the current fiscal year.
HCA has been the subject of a number of other recent research reports. Analysts at Citigroup Inc. reiterated a “buy” rating on shares of HCA Holdings in a research note on Wednesday. They now have a $84.00 price target on the stock, up previously from $60.00. Separately, analysts at Barclays reiterated an “overweight” rating on shares of HCA Holdings in a research note on Wednesday. They now have a $75.00 price target on the stock, up previously from $58.00. Finally, analysts at Oppenheimer raised their price target on shares of HCA Holdings from $62.00 to $74.00 in a research note on Wednesday. They now have an “outperform” rating on the stock. Two equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $67.71.
HCA Holdings, Inc (NYSE:HCA) is a holding company whose affiliates owns and operates hospitals and related health care entities.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.